NCT04633460View on ClinicalTrials.gov

Acute Effects of Exogenous Ketone Ester Administration in Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

October 4, 2023

Study Completion Date

October 16, 2023

Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
DIETARY_SUPPLEMENT

Ketone ester

A nutraceutical ketone ester (KE), (R)-3-hydroxybutyl (R)-3-hydroxybutyrate which provides systemic ketosis

DIETARY_SUPPLEMENT

placebo drink

KE free placebo drink

Trial Locations (1)

19104

Penn Presbyterian Medical Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04633460 - Acute Effects of Exogenous Ketone Ester Administration in Heart Failure | Biotech Hunter | Biotech Hunter